Market News & Trends
FDA Endorses, Pushes for Abuse-Resistant Opioid Formulations: Transition to Disrupt Pain Market
The opioid market is dominated by non-tamper-resistant formulations (TRFs), but the FDA’s promotion of TRF therapies could well result in the departure of non-TRF therapies…
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Growth in diagnostic test volume conducted across hospitals worldwide is lending momentum to the global tissue diagnostics market. In addition, the shortage of pathologists to…
Bladder Cancer Market to Witness Moderate Growth by 2017
The bladder cancer therapeutics market in the six major countries (6MM) - the US, France, Germany, Italy, Spain, and UK - is forecast to climb…
Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
A ground-breaking study spearheaded by Scientific Director Giulio Superti-Furga at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences shows that…
Noxilizer & Weiler Announce Exclusive Agreement for Blow/Fill/Seal Market
Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization process for life science manufacturers, and Weiler Engineering, Inc., a leader in the global Blow/Fill/Seal…
EMD Millipore Develops Simplified Protocol for Rapid Purification of Recombinant Proteins
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently introduced a new recombinant protein purification protocol that combines lysis and purification…
Novozymes’ VELTIS Technology Used in GlaxoSmithKline Drug Approved in Europe
Novozymes Biopharma DK A/S recently announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for…
Haselmeier Announces Market Launch of JuniorSTAR by Sanofi
The new and reusable half-unit insulin pen JuniorSTAR is now available in Germany. It is suitable for all insulin types of Sanofi. It provides individual…
Forma Therapeutics & Celgene Announce Expansive Alliance
FORMA Therapeutics recently announced a second strategic collaboration and option agreement with Celgene Corporation. This new collaboration will enable FORMA to extend its unique capabilities…
Overcoming Hurdles of HCMV Vaccine Development
Infections by Human Cytomegalovirus (HCMV) are among the medically most significant herpesvirus infections. About 30,000 to 40,000 infants p.a. are born already infected in the…
Carolina Medical Products Now CMP Pharma
Carolina Medical Products, Inc. (CMP) has officially changed its name to CMP Pharma. This new name more appropriately reflects the nature of its current business…
3M DDS Names New President & General Manager
3M Drug Delivery Systems recently announced the appointment of Cindy R. Kent as its new President and General Manager. She succeeds James Ingebrand, who was…
Catalent Increases Stake in Redwood Bioscience
Catalent Pharma Solutions recently announced that based on compelling data generated by the SMARTag ADC platform, it has increased its minority investment in Redwood Bioscience.…
Latest Frost Reports: Next-Generation Therapeutics for Infectious Diseases; Orphan Drugs Market
Next-Generation Therapeutics The available antivirals for commonly occurring infections, such as respiratory syncytial virus (RSV) and influenza are characterized by variable response, poor tolerability, and…
Pfanstiehl Launches cGMP-Produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media
Pfanstiehl recently announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7…
Ensysce Biosciences Receives Patent for siRNA Delivery
Ensysce Biosciences Inc. recently announced the US Patent Office has issued a Notice of Allowance for US Patent Application No. 13/175,314: Single-Walled Carbon Nanotube/siRNA Complexes…
Eveon & Leti Advance Smart Bolus-Type Micro-Pump for Drug Delivery
Eveon and CEA-Leti recently announced the demonstration of liquid-pumping for smart drug delivery in the bolus mode using a silicon-based micro-pump fabricated with a standard…
Gem Pharmaceuticals Announces $4.5-Million Financing for Phase II Trial
Gem Pharmaceuticals recently announced that current Gem board members/investors Diane Hendricks and Karl Leo have agreed to provide up to $4.5 million in new capital…
Rexam’s SOF’BAG: the Airless Package Now Available in 50 ml
Rexam Healthcare recently announced the latest version of its industry reference in airless package – the 50-ml Sof’Bag – in anticipation of the worldwide growth…
Global Migraine Market Value to Grow Modestly Despite Promising New Drugs
The global migraine treatment market value is expected to undergo a modest increase over the coming years, climbing from $2.5 billion in 2012 to $3.7…
